The authors thank all of the study participants for their willingness to provide data for this research project, and the authors are also indebted to all coworkers for their enthusiastic commitment.
The Gutenberg Health Study is funded by the government of Rhineland-Palatinate (Stiftung Rheinland-Pfalz für Innovation, contract AZ 961-386261/733); by the research programs Wissen schafft Zukunft and Center for Translational Vascular Biology of the Johannes Gutenberg University of Mainz; and by a contract with Boehringer Ingelheim and Philips Medical Systems, including an unrestricted grant for the Gutenberg Health Study.
Boehringer Ingelheim, Philips Medical Systems, and Novartis Pharma provided funding toward this study. There are no patents, products in development, or marketed products to declare. This does not alter the authors’ adherence to all of the journal policies on sharing data and materials. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. A.F., S.N., M.S.U., T.M., P.S.W., M.B., K.L., E.H., N.P., and A.K.S. conceived of and designed the study; A.F., S.N., M.S.U., and A.K.S. analyzed the data; A.F. wrote the paper; S.N., M.S.U., T.M., P.S.W., M.E.B., K.J.L., E.H., N.P., and A.K.S. critically revised the manuscript; and all authors read and approved the final manuscript. A.K.S. and P.S.W. had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Statistical analyses were performed by A.K.S.
This analysis presents clinical data regarding a large-scale, population-based cohort with ongoing follow-up examinations. This project represents a major scientific effort that maintained high methodological standards and followed detailed guidelines for analysis and publication to ensure sound scientific analyses at the highest level. The data are not available to the scientific community outside the established and controlled workflows and algorithms. To meet the general principle of verification and reproducibility of scientific findings, we offer access to our data through a local database at any time upon request, in accordance with the ethics vote. The GHS steering committee, which includes a member of each involved department and the coordinating principal investigator of the Gutenberg Health Study (P.S.W.), convenes once a month. The steering committee decides on internal and external access by researchers and use of the data and biomaterials based on a research proposals supplied by the researchers. Interested researchers can make their requests to the coordinating PI of the Gutenberg Health Study (
[email protected]). More detailed contact information is available at the homepage of the GHS (
www.gutenberghealthstudy.org).
Disclosure: A. Fieß, None; S. Nickels, Heidelberg Engineering (F); M.S. Urschitz, None; T. Münzel, None; P.S. Wild, Federal Ministry of Education and Research (R), German Center for Cardiovascular Research (F); M.E. Beutel, Pfizer Deutschland GmbH (F), Shire Deutschland GmbH (F), government of Rhineland-Palatinate (R), government of Nordrhein-Westfalen (R), German Association of Psychoanalysis and Psychotherapy (R), German Research Foundation (R), German Ministry of Research (R), German Cancer Aid (R), European Union (R); K.J. Lackner, None; E.M. Hoffmann, None; N. Pfeiffer, Novartis (F), Ivantis (F), Santen (F), Thea (F), Boehringer Ingelheim Deutschland GmbH & Co. KG (F), Alcon (F), Sanoculis (F); A.K. Schuster, Stiftung Auge (R), Deutsche Ophthalmologische Gesellschaft (F), Berufsverband der Augenärzte Deutschlands e.V. (F), Bayer Vital (F), Novartis (F), Heidelberg Engineering (F), Allergen (F), PlusOptix (F)